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Abstract
Background: It was recently reported that an interaction of the dopamine D2 receptor (DRD2) and
catechol-O-methyltransferase (COMT) influences the behavioural approach system – as measured using
Carver and White's Behavioural Inhibition and Behavioural Approach System (BIS/BAS) scales – in a sample
of healthy German subjects. The Temperament and Character Inventory (TCI), in particular the novelty
seeking (NS) and harm avoidance (HA) scales, correlates moderately with the BIS/BAS measure. This study
aimed to examine support for an association of DRD2 and COMT with behavioural activation, using the
TCI within two independent samples of depressed outpatients (for both samples n = 146).
Methods: Two clinical samples of depressed patients were ascertained to assess the efficacy of two
different pharmacotherapy and psychotherapy treatments. Analysis of variance (ANOVA) was used to
analyse NS and HA scale and subscale scores with respect to gene loci within each clinical sample. Analysis
of covariance were undertaken to examine the association of age and gender with NS and HA scores. An
association of age group or gender with gene loci were explored using chi-squared tests, in each sample.
Results: No significant effect of DRD2 or COMT, either independently or as an interaction, on NS or HA
scores was observed, within either sample. Whilst age was significantly negatively associated with NS
scores, including age in the two- and three-way interactions did not affect the significance of the association
of personality with gene loci.
Conclusion: This study suggests that the COMT-DRD2 Equilibrium Model of Positive Emotionality
recently proposed by Reuter and his colleagues is not applicable amongst currently depressed individuals,
whose behavioural approach and inhibition tendencies have been assessed using the TCI.
Published: 11 January 2007
Behavioral and Brain Functions 2007, 3:3 doi:10.1186/1744-9081-3-3
Received: 07 September 2006
Accepted: 11 January 2007
This article is available from: http://www.behavioralandbrainfunctions.com/content/3/1/3
© 2007 Light et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Behavioral and Brain Functions 2007, 3:3 http://www.behavioralandbrainfunctions.com/content/3/1/3
Page 2 of 6
(page number not for citation purposes)
Background
Reuter et al. [1] recently reported that the dopamine D2
receptor (DRD2) and catechol-O-methyltransferase
(COMT) genes are associated with variation in individu-
als' behavioural approach system. The DRD2 TaqI A1 and
COMT Val alleles were not individually associated with
behaviour, yet an interaction of the loci significantly pre-
dicted differences in response. An individual's behav-
ioural approach system (BAS), as well as their behavioural
inhibition system (BIS), were assessed using Carver and
White's [2] BIS/BAS scales. The BAS represents an individ-
ual's sensitivity to appetitive stimuli, such as reward or
avoidance of punishment [2]. Meanwhile, the BIS com-
prises an individual's inhibition towards goals due to sen-
sitivity to aversive stimuli or extreme novelty [2]. Reuter et
al. [1] found that higher BAS scores, in particular on the
'Drive' and 'Fun-seeking' scales, were observed in those
with Val-/A1- or Val+/A1+ genotype. No support was
found for an effect of these gene loci on the individuals'
BIS scores [1]. Gender had a significant effect on BIS
scores, both as an independent variable and in association
with the presence/absence of the COMT Met allele. Men
possessing the COMT Met allele had lower BIS scores than
men without this allele, whilst the inverse pattern
occurred amongst women [1].
DRD2 and COMT  have been investigated as candidate
genes for behaviour motivation because of their essential
roles within the dopamine system. The enzymatic activity
of COMT is attenuated by the occurrence of a single nucle-
otide polymorphism (G>A) which causes an amino acid
substitution (from a valine (Val) to a methionine (Met)
residue) at codon 158 [3]. The DRD2  TaqIA polymor-
phism is a single nucleotide transition which creates a
restriction fragment polymorphism [4]. The A1 allele has
been associated with a 30–40% reduction in D2
dopamine receptor density, compared to individuals
homozygous for the A2 allele [5-8]. Both polymorphisms
have been associated with measures of behavioural moti-
vation, including Cloninger's harm avoidance (HA) and
novelty seeking (NS) scales. Enoch et al. [9] found that
females homozygous for the COMT Met allele reported
the highest HA scores. Within two samples of young
males, the presence of the DRD2 TaqI A1 polymorphism
was associated with increased NS [10,11].
Carver and White's [2] BIS/BAS scales represent the oper-
ationalisation of Jeffrey Gray's Reinforcement Sensitivity
Theory. Gray and Cloninger's personality models are con-
ceptually equivalent [2]. They both theorise that human
behaviour is based on an interplay of at least two biolog-
ical self-regulatory systems – one which is responsive to
aversive stimuli (BIS or HA) and the other to appetitive
stimuli (BAS or NS). Concordantly, positive associations
have been found between HA and BIS, and NS and the
BAS fun-seeking scale [2,12]. This paper reports our find-
ing that DRD2 and COMT are not associated with behav-
ioural activation in two independent Caucasian samples
of depressed patients assessed with Cloninger's Tempera-




Patients were recruited for a study examining predictors of
outcome in depressed patients randomised to treatment
with either fluoxetine or nortriptyline [14]. Patients had
to be older than 18 years and have a principal current
diagnosis of major depression. Individuals were excluded
if they had a history of mania (i.e. bipolar I disorder),
schizophrenia, or a severe current alcohol or drug depend-
ence. Patients were required to have no serious physical
illness and to be free of psychotropic drugs for a mini-
mum of two weeks or five drug half lives.
Within the sample of 195 depressed patients, the mean
Montgomery-Asberg [15] depression score was 30.7 (±
6.6), 60% had recurrent depression and 48% met DSM-IV
criteria for melancholia. Complete genetic and personal-
ity data were available for 146 individuals, which
included 142 Europeans, three Maori and one Asian. Only
these 146 individuals have been included in the following
analyses.
Clinical sample 2
This clinical sample was recruited for a study examining
predictors of response to interpersonal psychotherapy
(IPT) and cognitive-behavioural therapy (CBT) amongst
depressed patients. Individuals were 18 years or older,
with a principal current diagnosis of major depression.
The exclusion criteria were the same as for clinical sample
1.
Within this sample of 177 depressed patients, the mean
Montgomery- Asberg depression score was 23.8 (± 6.4),
72% had recurrent depression and 38% met DSM-IV cri-
teria for melancholia. Only the 146 individuals for whom
complete genetic and personality data was available have
been included in the following analyses. The sample
included 127 Europeans, eight Asians, seven Maori, one
Pacific Islander and three individuals who identified as
'other'.
Assessment
Both clinical studies were approved by the Canterbury
(New Zealand) Ethics Committee. After giving informed
consent, the patients attended a detailed clinical and neu-
robiological assessment, which included giving a blood
sample for DNA extraction. The clinical assessment was
conducted by a psychiatrist or clinical psychologist usingBehavioral and Brain Functions 2007, 3:3 http://www.behavioralandbrainfunctions.com/content/3/1/3
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the Structured Clinical Interview for DSM-IV (SCID) [16].
Ratings on the Hamilton and Montgomery-Asberg depres-
sion rating scales were made. Patients completed a series
of self-report questionnaires, including the SCID Person-
ality Questionnaire (SCID-PQ) and the Temperament and
Character Inventory (TCI) [13]. After these baseline
assessments, patients in clinical sample 1 were ran-
domised to treatment with either fluoxetine or nortriptyl-
ine, and patients in clinical sample 2 were randomised to
treatment with either IPT or CBT. After commencing treat-
ment, a trained psychiatrist or clinical psychologist com-
pleted the SCID-II for DSM-IV [17] to assess the presence
of axis II personality disorders.
Laboratory methodology
The DRD2 TaqI A polymorphism was assayed as described
by Grandy et al. [18]. The COMT 158Val>Met variant was
determined using a specifically designed one-tube allele
specific PCR protocol. The G (Val) allele was detected
using the primers 5'-TCACCCAGCGGATGGTGGATT-
TCGCTGGGG-3' and 5'-AACGTGGTGTGAACACCTGGT-
GGGGAG-3', yielding a 143 bp product. The A (Met)
allele was detected with the primers 5'-CGGGTCAG-
GCATGCACACCTTGTCCTTCCT-3' and 5'-TGCTGTCAC-
CAGGGGCGAGGCTCATCA-3', generating a 116 bp
product. A 200 bp internal control band was also present.
All four primers were included in a 10 μl reaction with
20–100 ng genomic DNA, HotMaster Taq (Eppendorf™),
0.2 mM each dNTP and the enzyme supplier's buffer.
Thermal cycling conditions were 4 minutes at 94°C fol-
lowed by 30 cycles of 94°C, 62°C, and 68°C with 30 sec-
onds at each step. Products were resolved on 2% agarose
gels. The assay was validated by DNA sequencing on a
proportion of each sample.
Statistical methods
Consistent with Reuter et al. [1] the gene loci were consid-
ered in two ways: (1) presence of an allele (DRD2 TaqI A1
or  COMT  Val) and (2) genotype. Analysis of variance
(ANOVA) was used to analyse NS and HA scale scores
with respect to gene loci, analysing the main effect of each
gene loci and the two-way interaction of the loci, within
each clinical sample. Effect sizes for the presence of each
allele in relation to HA and NS scores, in both samples,
were calculated. A separate ANOVA was used to evaluate
the scores on each NS and HA subscale in relation to the
presence of an allele. Analysis of covariance and Least Sig-
nificant Difference post-hoc tests were undertaken to
examine the association of age and gender with NS and
HA scores, within the two samples. To identify the effect
of more substantial changes in age, the following age
groups were used: 18–29 years, 30–39 years and 40+
years. Chi-squared tests were used to examine any associ-
ation of age or gender with gene loci, within the samples.
Based on the concordance of the samples with respect to
ascertainment criteria and assessment method, the sam-
ples were combined. The collective sample was analysed
within a univariate linear model of NS and HA scores,
encompassing the main effects of gene loci, age group and
gender, as well as all two-way and three-way interactions
involving gene loci. To account for any differences




Within clinical sample 1, 40% were male and 97% were
Caucasian. The mean age was 31.7 years (SD 11.4 years).
80 individuals were aged 18–29 years, 26 were 30–39
years and 40 were 40+ years. The DRD2 TaqI A1 and A2
allele frequencies were .22 and .78, respectively. The fre-
quency of the COMT Met allele was .49 and the Val allele
was .51. The mean (± SD) NS score was 51.6 (± 16.4) and
HA score was 67.3 (± 20.3).
Clinical sample 2 consisted of 28% males and 89% Cau-
casians. The mean age was 35.0 years (SD 9.8 years). Forty
seven individuals were 18–29 years, 53 were 30–39 years
and 46 were 40+ years. Within this sample, the DRD2
TaqI A1 allele frequency was .28 and the A2 allele in .72.
The COMT Met and Val allele frequencies were .46 and
.54, respectively. The allele frequencies at both loci in each
sample were in Hardy-Weinberg equilibrium. The mean
(± SD) NS score was 47.8 (± 15.1) and HA score was 71.1
(± 18.6).
Associations between personality and gene loci
There was no support for a main effect of DRD2 or COMT
in either sample, irrespective of whether individuals were
characterised by genotype or presence of the A1 or Val
allele, on HA or NS scores. The effect sizes of the A1 and
Val alleles on NS scores were 0.18 and 0.018 in sample 1.
In sample 2, the effect sizes were 0.02 and 0.03, respec-
tively. The gene loci were not related to HA scores in sam-
ple 1 (effect sizes: A1= 0.07 and COMT = 0.10) or sample
2 (effect sizes: A1 = 0.10 and COMT = 0.05). We found no
significant interactions of DRD2 TaqI A1 allele × COMT
Val allele for either HA or NS, within either sample (Table
1). Furthermore, there was no significant effect of gene
loci on any HA or NS subscale score.
Association of gender and age with personality and gene 
loci
There was no significant association of gender with NS
and HA scores within either sample. Age was significantly
associated with NS, but not HA, scores within sample 1
(F(2, 143) = 13.61, p = <0.001) and sample 2 (F(2,143) =
7.06, p = 0.001). Within sample 1, individuals aged 18–
29 years had significantly higher NS scores than thoseBehavioral and Brain Functions 2007, 3:3 http://www.behavioralandbrainfunctions.com/content/3/1/3
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aged over 30 years. Within sample 2, individuals who
were younger than 39 years scored significantly higher
than those who were 40+ years.
No significant association of gender with genotype or
allele frequency of DRD2  and  COMT  was observed in
either sample. Similarly, there was no significant associa-
tion of age and DRD2 or COMT.
Association of personality with gene loci, age and gender, 
within a combined sample
We tested all possible two-way interactions (gene loci ×
age/gender) and three-way interactions (DRD2 × COMT ×
age/gender), with respect to NS and HA total scale scores,
in the combined sample and found no significant associ-
ation.
Discussion
We found no support for an association of DRD2 TaqI A
and  COMT  Val polymorphisms with an individual's
behavioural approach response, using the TCI NS scale in
two samples of depressed patients. The effect size associ-
ated with the presence of either the A1 or Val allele on NS
scores was very small (<0.18) providing strong evidence
that the lack of association was not the result of inade-
quate statistical power. This contrasts with Reuter et al.'s
[1] findings that these genes epistatically influence fun-
seeking scores – which are correlated with TCI NS scores.
Consistent with our findings, Enoch et al. [9] found that
the COMT Val polymorphism was not associated with NS
in either a Caucasian or an American Indian community
sample. In contrast, Tsai et al. [19] in a sample of Chinese
female nursing students found that individuals
homozygous for the Val allele had higher NS [19]. Noble
et al. [10] reported a significant association of NS with the
DRD2 TaqI A polymorphism and DRD2 haplotype (TaqI
A, TaqI B and intron 6 polymorphisms), although the
association was significant for only one NS subscale. Con-
versely, Lee et al. [20] found no association between these
three DRD2 polymorphisms and NS or HA scores, within
Table 1: Mean (+ SD) novelty seeking and harm avoidance scores dependent on an individual's COMT and DRD2 genotype
DRD2 COMT N Mean (± SD)
Clinical Sample 1
Novelty seeking
A1 absent Val absent 19 56.2 ± 14.0
Val present 69 51.8 ± 18.3
A1 present Val absent 19 47.4 ± 13.6
Val present 39 51.0 ± 15.1
DRD2 main effect F (1,142) = 2.38, p = 0.125
COMT main effect F (1,142) = 0.015, p = 0.901
DRD2 × COMT F (1,142) = 1.62, p = 0.206
Harm avoidance
A1 absent Val absent 19 70.8 ± 15.9
Val present 69 67.0 ± 21.0
A1 present Val absent 19 66.9 ± 23.4
Val present 39 66.3 ± 19.8
DRD2 main effect F (1,142) = 0.356, p = 0.552
COMT main effect F (1,142) = 0.319, p = 0.573
DRD2 × COMT F (1,142) = 0.165, p = 0.685
Clinical Sample 2
Novelty seeking
A1 absent Val absent 16 48.3 ± 18.5
Val present 62 47.9 ± 15.9
A1 present Val absent 14 46.4 ± 12.5
Val present 54 47.9 ± 14.0
DRD2 main effect F (1,142) = 0.087, p = 0.769
COMT main effect F (1,142) = 0.027, p = 0.870
DRD2 × COMT F (1,142) = 0.088, p = 0.767
Harm avoidance
A1 absent Val absent 16 70.7 ± 18.1
Val present 62 72.3 ± 15.9
A1 present Val absent 14 73.1 ± 17.5
Val present 54 69.3 ± 22.1
DRD2 main effect F (1,142) = 0.008, p = 0.928
COMT main effect F (1,142) = 0.082, p = 0.775
DRD2 × COMT F (1,142) = 0.489, p = 0.485Behavioral and Brain Functions 2007, 3:3 http://www.behavioralandbrainfunctions.com/content/3/1/3
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a young Korean sample. Investigating two other DRD2
polymorphisms – Ser311Cys and -141Ins/del – within an
Austrian and Japanese sample, Gebhardt et al. [21] and
Katsuragi et al. [22], respectively, found no support for an
association with either NS or HA.
We found no association of DRD2 and COMT polymor-
phisms with individuals' behavioural inhibition – based
on TCI HA scores – consistent with Reuter et al. [1]. Simi-
larly, Noble et al. [10] found that DRD2, examined either
as the TaqI A allele or as a haplotype, was not associated
with HA. These findings do not discount the possibility
that these genes are at some stage involved in the develop-
ment of this self-regulatory system, but rather suggest that
their effect is moderated by other variables. For example,
Enoch et al. [9] found that COMT was only associated
with HA amongst female but not male subjects.
Within our samples, gender did not significantly effect
behavioural inhibition scores – as found by Reuter et al.
[1]. However, we found support for the finding that NS
declines with age [23,24], whereby individuals aged 18–
29 years scored consistently higher than individuals 40+
years. Although, in the two-way and three-way interac-
tion, age did not alter the significance of the gene loci
effects.
Two evident sources of difference between our investiga-
tion and that of the original study are the personality
measure used and the sample composition. Reuter et al.
[1] found a significant association with two of the three
BAS subscales. One of these scales 'fun seeking' correlates
moderately with NS (r =.51, p <.001), whilst the other
'drive' does not [2]. Therefore, the BIS/BAS scales evaluate
behavioural approach tendencies from a slightly different
perspective to that of the TCI. Reuter et al. [1] examined
healthy subjects, whilst all our participants had a current
major depressive disorder. A genetic association may be
more evident in a community sample which includes a
range of behavioural approach and inhibition responses,
whilst our samples of depressed patients may be heavily
weighted for high HA [24,25]. Also, as our sample is not
primarily of German origin, it differs from Reuter et al.'s
[1] with respect to ethnicity and therefore genetic hetero-
geneity may partly be responsible for the different results.
Variable findings may also reflect a lack of a direct effect
of a polymorphism on the function of the gene product.
For example, the functional effects associated with the
DRD2 TaqI A polymorphism may be due to the polymor-
phism being located within the regulatory region of the
ankyrin repeat and kinase domain containing 1 (ANKK1)
gene [26] or being in linkage disequilibrium with another
DRD2 variant. This indistinctness may be further com-
pounded by grouping A1A1 carriers with A1A2 carriers
(due to the low frequency of the A1 allele) for analysis.
Whether this is an accurate representation of the function-
ality of the polymorphism remains to be determined.
Conclusion
This study suggests that the association found by Reuter et
al. [1] does not hold in a sample of depressed patients
assessed using the TCI. Although, due to the interplay of
metabolising enzymes and receptors it is expected that at
some level these genetic factors are interdependent, yet
how these facets might interact to influence personality
remains unknown. Appraisal of both positive and nega-
tive results will hopefully provide some clues as to the
contexts in which associations exist between genetic fac-
tors and specifically-defined behaviours.
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